Ignite Creation Date:
2024-05-06 @ 7:28 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06022029
Status:
RECRUITING
Last Update Posted:
2024-03-28
First Post:
2023-08-15
Brief Title:
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas
Sponsor:
OncoNano Medicine Inc
Organization:
OncoNano Medicine Inc
Organization Data
Organization:
OncoNano Medicine Inc
Class:
INDUSTRY
Study ID:
ON-5001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
OncoNano Medicine Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None